Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$9.64 - $14.59 $57,840 - $87,540
6,000 Added 17.96%
39,400 $556,000
Q3 2023

Nov 15, 2023

BUY
$10.3 - $15.99 $162,740 - $252,642
15,800 Added 89.77%
33,400 $344,000
Q2 2023

Aug 23, 2023

BUY
$8.48 - $16.48 $149,248 - $290,048
17,600 New
17,600 $290,000
Q2 2022

Aug 15, 2022

BUY
$1.07 - $6.95 $1,284 - $8,340
1,200 Added 9.68%
13,600 $32,000
Q1 2022

May 16, 2022

BUY
$5.46 - $8.29 $67,704 - $102,795
12,400 New
12,400 $87,000
Q3 2021

Nov 12, 2021

SELL
$6.49 - $9.91 $66,847 - $102,073
-10,300 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$6.73 - $9.05 $29,612 - $39,820
-4,400 Reduced 29.93%
10,300 $72,000
Q1 2021

May 14, 2021

SELL
$6.61 - $10.07 $1,983 - $3,021
-300 Reduced 2.0%
14,700 $130,000
Q4 2020

Feb 12, 2021

SELL
$5.03 - $7.95 $25,653 - $40,545
-5,100 Reduced 25.37%
15,000 $100,000
Q3 2020

Nov 13, 2020

SELL
$5.02 - $8.98 $123,491 - $220,908
-24,600 Reduced 55.03%
20,100 $103,000
Q2 2020

Aug 13, 2020

SELL
$7.25 - $11.75 $245,775 - $398,325
-33,900 Reduced 43.13%
44,700 $355,000
Q1 2020

May 11, 2020

BUY
$4.06 - $10.64 $319,115 - $836,304
78,600 New
78,600 $685,000
Q4 2019

Feb 12, 2020

SELL
$3.34 - $7.7 $150,634 - $347,270
-45,100 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.92 - $4.47 $86,592 - $201,597
45,100 New
45,100 $192,000
Q3 2018

Nov 14, 2018

SELL
$4.08 - $7.14 $66,096 - $115,668
-16,200 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$6.76 - $11.7 $109,512 - $189,540
16,200 New
16,200 $118,000

Others Institutions Holding AVDL

About AVADEL PHARMACEUTICALS PLC


  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $650M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.